MassBio’s President & CEO, Bob Coughlin, will host a weekly virtual Town Hall for members. Learn More
Join MassBio as President and CEO, Bob Coughlin, introduces key industry and policy experts who will break down the details of the Coronavirus Aid, Relief, and Economic Security (CARES) Act and how it may impact your business. Learn More
Join MassBio's Director of Events, Laura Rudberg, for a 45 minute total body Virtual workout. No Equipment required. Learn More
MassBio’s President & CEO, Bob Coughlin, will host a weekly virtual Town Hall for members. Learn More
MassBio’s President & CEO, Bob Coughlin, will host a weekly virtual Town Hall for members. Learn More
This four-session, intensive online course is designed to help scientists and technical experts confidently develop and deliver persuasive messaging to investors, policymakers, employers, the public, and other key stakeholders to concisely convey the real-world value of their work. Participants learn how to communicate their science to non-experts in relatable terms without sacrificing accuracy. Learn More
This interactive online course focuses on how leaders can drive performance and positively shape the culture of the workplace to maximize employee and stakeholder engagement. Participants engage in activities and learn the skills needed to address common coaching challenges. Participants will also learn how to manage effective team communication and facilitate productive meetings remotely. Learn More
MassBio’s President & CEO, Bob Coughlin, will host a weekly virtual Town Hall for members. Learn More
Participants of this interactive online course will gain a clear understanding of the leader-manager they aim to be and the essential skills and strategies to help them get there. Approaches to effective communication and how to foster collaboration among teams, both remotely and in-person are discussed. Participants will learn the fundamentals for interviewing and hiring, and more. Learn More
A panel of experts, including Brad Loncar, will familiarize the audience with the current state of the biopharma industry in China and the novel approaches they are seeing in the market as well as the impact of the coronavirus. They’ll discuss what this means for the MassBio community and the US biopharma industry, what US companies are doing to take advantage of the market. Learn More